Hims & Hers Health, Inc. reports results for the quarter ended September 30 - Earnings Summary

What happened

Hims & Hers Health reported an adjusted loss of 10 cents per share for the quarter ended September 30, versus earnings of 6 cents per share a year earlier. Revenue rose 48.6% to $890.37 million, below analysts’ $892.91 million expectation, while the company reported a net loss of $33.04 million.

Confirmed

Global impact / market context

The faster revenue growth shows sales expanded, but the quarterly loss and missed revenue expectation point to pressure on the path to profitable growth. If losses persist, the company may have less cash available to fund operations or expansion without reducing spending or seeking financing.

Analyst inference

Analysts had expected earnings of 6 cents per share, while the adjusted result was a loss of 10 cents; their average earnings estimate had also fallen about 51% over three months. The average rating was hold, and shares were down 19.9% year to date.

Confirmed

What to watch

1. Compare upcoming revenue with expectations and the recent 48.6% growth rate; sustained growth could support sales, but repeated shortfalls may weaken confidence in expansion plans. Analyst inference
2. Watch whether quarterly losses narrow and the company reports improved profitability; smaller losses would reduce the cash needed to support operations and growth. Analyst inference
3. Track analyst estimate changes and recommendations: the average rating is hold, with four buy or strong-buy ratings and twelve hold ratings. Confirmed

Evidence

• Original source link unavailable